Samsung BioLogics confirmed Thursday morning that it will officially pursue an initial public offering on South Korea’s main bourse KOSPI.
|
(Samsung BioLogics) |
The decision will be confirmed at the company’s board meeting today, which starts at 9 a.m., Korean time. The firm will reveal the specific details of its scheduled IPO after the meeting concludes.
By Sohn Ji-young (
jys@heraldcorp.com)